![Florian Jehle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Florian Jehle
Verkställande Direktör på
Vifor Fresenius Medical Care Renal Pharma Ltd.
Profil
Florian Jehle currently works at Vifor Fresenius Medical Care Renal Pharma Ltd., as Chief Executive Officer from 2022 and Fresenius Medical Care Ventures GmbH, as Managing Director from 2016.
Aktiva positioner av Florian Jehle
| Företag | Position | Start |
|---|---|---|
Fresenius Medical Care Ventures GmbH
 Fresenius Medical Care Ventures GmbH Investment ManagersFinance Fresenius Medical Care Ventures provides financing for early stage capital requirements. It invests in companies that develop technologies, products, and therapies for patients and the healthcare system. It targets companies located in Europe and North America that operate in the fields of medical devices, patient monitoring, eHealth solutions, regenerative medicine, and pharmaceuticals. | Direktör/Styrelseledamot | 2016-02-10 |
Vifor Fresenius Medical Care Renal Pharma Ltd.
 Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies for patients with chronic kidney disease | Verkställande Direktör | 2022-04-01 |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
15
Första gradens relationer
2
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 2 |
|---|---|
Vifor Fresenius Medical Care Renal Pharma Ltd.
Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies for patients with chronic kidney disease | Health Technology |
Fresenius Medical Care Ventures GmbH
Fresenius Medical Care Ventures GmbH Investment ManagersFinance Fresenius Medical Care Ventures provides financing for early stage capital requirements. It invests in companies that develop technologies, products, and therapies for patients and the healthcare system. It targets companies located in Europe and North America that operate in the fields of medical devices, patient monitoring, eHealth solutions, regenerative medicine, and pharmaceuticals. | Finance |
